INNOVATE BIOPHARMACEUTICALS, INC. (INNT) has 19 open-market insider trades by 6 insiders since 2016. The most active filer is Sandeep Laumas, CEO & Chairman.
| Name | Title | Tier | Trades | Value | Last Trade |
|---|---|---|---|---|---|
| David H. Clarke | CEODir | — | 1 | $807K | 2018-01-26 |
| Sandeep Laumas | CEOChairman | — | 9 | $39K | 2019-06-28 |
| Christopher P. Prior | CEO | — | 5 | $25K | 2018-11-29 |
| June Sherie Almenoff | COO and Chief Medical Officer | — | 1 | $7K | 2018-08-27 |
| Jay P. Madan | Pres | — | 1 | $7K | 2019-05-30 |
| Roy Proujansky | Dir | — | 2 | $5K | 2019-05-24 |
| Insider | Title | Type | Value | Date |
|---|---|---|---|---|
| Sandeep Laumas | CEO & Chairman | Buy | $5K | 2019-06-28 |
| Sandeep Laumas | CEO & Chairman | Buy | $1K | 2019-06-13 |
| Jay P. Madan | President | Buy | $7K | 2019-05-30 |
| Roy Proujansky | Director | Buy | $1K | 2019-05-24 |
| Sandeep Laumas | CEO & Chairman | Buy | $7K | 2019-05-22 |
| Roy Proujansky | Director | Buy | $4K | 2018-11-30 |
Companies that share insiders with INNT, and sector peers with recent insider buying. Related by who files, not by how the stocks move.
| Sandeep Laumas | Chairman | Buy | $8K | 2018-11-30 |
| Sandeep Laumas | Chairman | Buy | $8K | 2018-11-29 |
| Christopher P. Prior | CEO | Buy | $14K | 2018-11-29 |
| Christopher P. Prior | CEO | Buy | $1K | 2018-09-14 |
| Christopher P. Prior | CEO | Buy | $3K | 2018-09-12 |
| Sandeep Laumas | Chairman | Buy | $3K | 2018-09-07 |
| Sandeep Laumas | Chairman | Buy | $3K | 2018-08-30 |
| Christopher P. Prior | CEO | Buy | $2K | 2018-08-30 |
| Sandeep Laumas | Chairman | Buy | $4K | 2018-08-28 |